Replies to post #145338 on Biotech Values

[Superfly15]

GNOM - it's nowhere near as "advanced" as a DNDN/ARNA one, but they have their own cult-like following. Not very familiar with the company itself though.

[DewDiligence]

The innovation is genuine, but GNOM’s PR neglects to mention the participation of other parties in the research effort; from today’s WSJ:

http://online.wsj.com/article/SB10001424052702303644004577520851224339844.html

A new method of mapping people's DNA promises to make the procedure more accessible to patients and to help doctors zero in on gene mutations that may cause disease, according to a report Wednesday in the journal Nature… The new research, conducted along with scientists from Harvard Medical School and Boston University, was funded largely by Complete Genomics, with some work backed by federal grants.